Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTriad Regulatory News (TRD)

Share Price Information for Triad (TRD)

Share Price is delayed by 15 minutes
Get Live Data
285.00    0.00 (0.00%)
Bid:
280.00
Ask:
290.00
Spread: 10.00 (3.571%)
Market Cap: £49.67m
TRD Live PriceLast checked at - London Stock Exchange

Intraday Triad Share Chart

Director/PDMR Shareholding

15 Mar 2012 09:54

RNS Number : 4083Z
Triad Group Plc
15 March 2012
 



Notification of Transactions of Directors/Persons Discharging Managerial Responsibility and Connected Persons

 

 

1.

Name of the issuer

 

TRIAD GROUP PLC

 

 

 

 

 

2.

State whether the notification relates to

(i) a transaction notified in accordance with DTR 3.1.2 R,

(ii) a disclosure made in accordance LR 9.8.6R(1) or

(iii) a disclosure made in accordance with section 793 of the Companies Act (2006).

 

RELATES TO (i) ONLY

 

3.

Name of person discharging managerial

responsibilities/director

 

STEVEN SANDERSON

 

 

 

4.

State whether notification relates to a person connected with a person discharging managerial responsibilities/director named in 3 and identify the connected person

 

DOES NOT RELATE TO A PERSON CONNECTED TO THE PERSON NAMED IN 3

 

5.

Indicate whether the notification is in respect of a holding of the person referred to in 3 or 4 above or in respect of a non-beneficial interest

 

IN RESPECT OF A HOLDING OF THE PERSON REFERRED TO IN 3

 

6.

Description of shares (including class), debentures or derivatives or financial instruments relating to shares

 

ORDINARY SHARES OF 1P EACH

 

 

7.

Name of registered shareholders(s) and, if more than one, the number of shares held by each of them

 

HSDL NOMINEES LIMITED

 

8.

State the nature of the transaction

 

ACQUISITION

 

 

 

9.

Number of shares, debentures or financial instruments relating to shares acquired

 

17,983 ORDINARY SHARES

 

 

10.

Percentage of issued class acquired (treasury shares of that class should not be taken into account when calculating percentage)

 

0.12%

 

11.

Number of shares, debentures or financial instruments relating to shares disposed

 

N/A

 

 

12.

Percentage of issued class disposed (treasury shares of that class should not be taken into account when calculating percentage)

 

N/A

 

13.

Price per share or value of transaction

 

11.0 PENCE PER SHARE

 

14.

Date and place of transaction

 

13 MARCH 2012 - LONDON

 

15.

Total holding following notification and total percentage holding following notification (any treasury shares should not be taken into account when calculating percentage)

 

104,089 ORDINARY SHARES : 0.69%

 

16.

Date issuer informed of transaction

 

 

15 MARCH 2012

 

 

 

 

 

If a person discharging managerial responsibilities has been granted options by the issuer

complete the following boxes

 

17.

Date of grant

 

N/A

 

 

18.

Period during which or date on which exercisable

 

N/A

 

19.

Total amount paid (if any) for grant of the option

 

N/A

20.

Description of shares or debentures involved (class and number)

 

N/A

 

21.

Exercise price (if fixed at time of grant) or indication that price is to be fixed at the time of exercise

 

N/A

22.

Total number of shares or debentures over which options held following notification

 

N/A

 

 

 

23.

Any additional information

 

 

 

 

24.

Name of contact and telephone number for queries

 

NICK BURROWS - 01483 860222

 

 

Name of authorised official of issuer responsible for making notification

 

NICK BURROWS

 

Date of notification 15 MARCH 2012

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSUVUKRUKAOARR
Date   Source Headline
2nd Mar 20261:00 pmRNSDirectorate change
5th Feb 202611:00 amRNSDirector/PDMR Shareholding
27th Jan 20262:00 pmRNSDirector Dealing
20th Jan 20262:30 pmRNSDirector/PDMR Shareholding
23rd Dec 202512:00 pmRNSTotal Voting Rights
23rd Dec 202512:00 pmRNSTotal Voting Rights
25th Nov 20257:00 amRNSHalf-year Financial Report
26th Sep 20253:00 pmRNSDirector dealings
15th Sep 202512:00 pmRNSBlock listing Review
20th Aug 20252:30 pmRNSNotification of Major Holdings
18th Aug 20252:00 pmRNSDirector/PDMR Shareholding
30th Jul 202510:30 amRNSResult of AGM
7th Jul 20253:45 pmRNSNotice of AGM and Dividend declaration
2nd Jul 202510:30 amRNSDirector/PDMR Shareholding
16th Jun 20257:00 amRNSFinal Results
1st Apr 202511:00 amRNSDirector/PDMR Shareholding and Total Voting Rights
19th Mar 20254:00 pmRNSDirector/PDMR Shareholding
14th Mar 20252:00 pmRNSBlock listing Review
7th Nov 20247:00 amRNSHalf-year Report
5th Nov 20244:30 pmRNSCommittee changes
30th Sep 20242:00 pmRNSDirector/PDMR Shareholding
23rd Sep 20242:00 pmRNSDirector/PDMR Shareholding
20th Sep 20242:00 pmRNSDirectorate Change
16th Sep 20242:30 pmRNSBlock listing Interim Review
5th Sep 202412:00 pmRNSHolding(s) in Company
23rd Aug 20242:00 pmRNSResult of AGM
22nd Aug 202411:00 amRNSTrading Statement
9th Aug 20243:00 pmRNSHolding(s) in Company
31st Jul 20243:00 pmRNSNotice of AGM
31st Jul 20242:00 pmRNSDirector/PDMR Shareholding
31st Jul 20242:00 pmRNSHolding(s) in Company
29th Jul 20242:00 pmRNSDirector/PDMR Shareholding
25th Jul 20242:00 pmRNSDividend and AGM declaration
25th Jul 20242:00 pmRNSTotal Voting Rights
15th Jul 202410:00 amRNSHolding(s) in Company
11th Jul 202411:45 amRNSDirector/PDMR Shareholding
10th Jul 20241:57 pmRNSHolding(s) in Company
10th Jul 20241:55 pmRNSHolding(s) in Company
10th Jul 20241:50 pmRNSHolding(s) in Company
3rd Jul 202412:30 pmRNSDirector/PDMR Shareholding
3rd Jul 202412:30 pmRNSHolding(s) in Company
3rd Jul 202412:30 pmRNSDirector/PDMR Shareholding
3rd Jul 202412:30 pmRNSDirector/PDMR Shareholding
1st Jul 20243:00 pmRNSDirectorate Change
26th Jun 20247:00 amRNSAnnual Financial Report
14th Jun 202412:00 pmRNSHolding(s) in Company
3rd Jun 202410:00 amRNSTotal Voting Rights
1st May 20245:00 pmRNSHolding(s) in Company
1st May 20245:00 pmRNSTotal Voting Rights
14th Mar 20243:00 pmRNSBlock listing Interim Review

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.